Cynosure Management, LLC Vericel Corp Transaction History
Cynosure Management, LLC
- $854 Million
- Q2 2025
A detailed history of Cynosure Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Cynosure Management, LLC holds 9,527 shares of VCEL stock, worth $303,434. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,527
Previous 6,615
44.02%
Holding current value
$303,434
Previous $295,000
37.29%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$257 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$113 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$89.6 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$78.5 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$77.6 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.5B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...